Drug resistance and the solid tumor microenvironment.
By O. Trédan, Carlos M. Galmarini, Krupa J. Patel, I. Tannock. Journal of the National Cancer Institute, 2007
2,057 citations recorded by the source corpus.
Subfields: Biotechnology, Cancer Research, Oncology
View Paper: https://www.semanticscholar.org/paper/08b1c43958dbb249104e14404ef6b266611e5d76
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Bouchra El Hafny-Rahbi
- Peter L. Choyke
- Hisataka Kobayashi
- David M. Sabatini
- A. Matejuk
- Aude Carreau
- C. Kieda
- C. Grillon
In Oncology
Citations in the corpus
- Harnessing nanotopography and integrin-matrix interactions to influence stem cell fate. (2014, background): “Journal of the National Cancer Institute 99(19):1441–54 [122].”
- Strategies to improve radiotherapy with targeted drugs (2011, background): “Hypoxic cells are often non-dividing and difficult to reach by drugs, also rendering them resistant to many chemotherapeutic agent”
- Cancer Cell Metabolism: One Hallmark, Many Faces (2012, background): “Solid tumors are poorly vascularized, and therefore their surrounding environment can subject distinct regions of the tumor to spatial and temporal gradients of oxygenation, pH, and nutrient availability (145).”
- Spheroids-on-a-chip: Recent advances and design considerations in microfluidic platforms for spheroid formation and culture (2018, background): “Compared to 2D-monolayers, cancer cells cultured in 3D spheroids are more resistant to anticancer drugs [10-18] and photodynamic therapy [13], reflecting differences in cell secretions, hypoxia, species concentration, and proliferative gradients [8, 14, 19].”
- The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition (2016, background): “The resulting reactive stroma and dense extracellular matrix create a barrier to the infiltration of immune cells within the tumor which manifests into an excluded infiltrate phenotype with peritumoral or stromal T-cell localization (15).”
- Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia (2011, background): “Tumour cells are highly unresponsive to most anticancer drugs [31].”
- Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma (2012, background): “Thus, although HA has been implicated in a variety of cell autonomous and noncell autonomous processes, its precise role(s) in therapeutic resistance of cancers has remained elusive and is likely context specific (reviewed in Toole and Slomiany, 2008; Trédan et al., 2007).”
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target? (2013, background): “(28, 29) Microscopy reveals that tumor cells grow as sleeves or sheaths concentric with tumor vessels.”